Last updated on July 2019

A Study To Investigate The Pharmacokinetics Safety And Tolerability Of Subcutaneous Ocrelizumab Administration In Patients With Multiple Sclerosis


Brief description of study

This study will evaluate the pharmacokinetics, safety and tolerability, and immunogenicity of ocrelizumab administered subcutaneously to patients with multiple sclerosis (MS).

Clinical Study Identifier: NCT03972306

Find a site near you

Start Over

Advanced Neurosciences Res LLC

Fort Collins, CO United States
  Connect »

Riverside Clinical Research

Edgewater, FL United States
  Connect »

Consultants in Neurology Ltd

Northbrook, IL United States
  Connect »

UC Health Neurology

Dayton, OH United States
  Connect »

MDH Research LLC

Westerville, OH United States
  Connect »

University of Pennsylvania

Philadelphia, PA United States
  Connect »

University of Pittsburgh

Pittsburgh, PA United States
  Connect »

Premier Neurology

Greer, SC United States
  Connect »

Neurology Clinic PC

Cordova, TN United States
  Connect »